# A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-cost-effectiveness-analysis-of-denosumab-for-the-prevention-of-skeletal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Noopur Raje,G. David Roodman,Wolfgang Willenbacher,Kazuyuki Shimizu,Ramón García‐Sánz,Evangelos Terpos,Lisa Kennedy,Lorenzo Sabatelli,Michele Intorcia,Guy Hechmati |
| Citations | 25 |
| DOI | 10.1080/13696998.2018.1445634 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/13696998.2018.1445634?needAccess=true&role=button |
| OpenAlex ID | https://openalex.org/W2789852769 |
| PMID | 29480139 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Lorenzo Sabatelli](https://scholariq.org/researchers/lorenzo-sabatelli/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Management of metastatic bone disease](https://scholariq.org/topics/management-of-metastatic-bone-disease/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.